IL1B and rheumatoid arthritis: The present study shows that the CTLA-4-Ig fusion protein is able to downregulate SM activation (co-cultured with T cells) by interacting with the B7.2 molecule expressed on their surface and by decreasing their production of inflammatory RA cytokines (IL-6, TNFα, IL-1β).